Seres Therapeutics Inc. (MCRB) |
|
3.51 -0.05 (-1.4%)
|
02-14 16:00 |
|
Open: |
3.55 |
Pre. Close: |
3.56 |
|
High:
|
3.73 |
Low:
|
3.49 |
|
Volume:
|
186,296 |
Market Cap:
|
242M |
|
|
|
|
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.736 - 3.762 |
3.762 - 3.782 |
|
Low:
|
3.424 - 3.458 |
3.458 - 3.485 |
|
Close:
|
3.463 - 3.509 |
3.509 - 3.544 |
|
Technical analysis |
as of: 2020-02-14 4:30:37 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.44 One year: 5.18 |
| Support: |
Support1: 3.21 Support2: 2.85 |
| Resistance: |
Resistance1: 3.80 Resistance2: 4.44 |
| Pivot: |
3.48  |
| Moving Average: |
MA(5): 3.60  MA(20): 3.45
MA(100): 3.61 MA(250): 4.11 |
| MACD: |
MACD(12,26): 0.03 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 72.03 %D(3): 77.23 |
| RSI: |
RSI(14): 50.22 |
| 52-week: |
High: 8.39 Low: 2.02 Change(%): -41.5 |
| Average Vol(K): |
3-Month: 21377 10-Days: 20064 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.MCRB has closed below upper band by 44.9%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-12-16
Seres Therapeutics Appoints Stephen Berenson as Chairman of its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics announces the appointment of Stephen Berenson as Chairman of its Board of Directors.
2019-11-25
Human Microbiome World Markets to 2023, Featuring Chr. Hansen, Enterome Bioscience, Seres Therapeutics, and Viome
DUBLIN, Nov. 25, 2019 /PRNewswire/ -- The "Growth Opportunities in Human Microbiome Market, Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. This study highlights the growth opportunities, visioning scenarios, innovative business models/use cases, competitive…
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
